| scholarly article | Q13442814 |
| P50 | author | Marc G Achen | Q50780476 |
| P2093 | author name string | Ikeda E | |
| Breier G | |||
| Risau W | |||
| P2860 | cites work | A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation | Q24294741 |
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis | Q28594191 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Angiogenic factors | Q29620582 | ||
| Clonal expansion of p53 mutant cells is associated with brain tumour progression | Q34233614 | ||
| Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells | Q34259539 | ||
| Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer | Q35578323 | ||
| The nucleotide sequence of the chick cytoplasmic β-actin gene | Q35693846 | ||
| Angiogenic growth factors | Q36682043 | ||
| The FixL protein of Rhizobium meliloti can be separated into a heme-binding oxygen-sensing domain and a functional C-terminal kinase domain | Q37000795 | ||
| A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter | Q38994284 | ||
| Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein | Q41337564 | ||
| Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant | Q41488146 | ||
| Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 | ||
| A haemoprotein with kinase activity encoded by the oxygen sensor of Rhizobium meliloti | Q46078006 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| hypoxia | Q105688 | ||
| P304 | page(s) | 19761-19766 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. | |
| P478 | volume | 270 |
| Q33959693 | 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples |
| Q26772837 | A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia |
| Q45767985 | A novel variant in the 3' UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding |
| Q34687036 | A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma |
| Q33888193 | A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor |
| Q34899860 | A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology |
| Q53572840 | AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. |
| Q40426107 | Activation of hypoxia-induced transcription in normoxia |
| Q24316075 | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 |
| Q38341890 | Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells |
| Q47952081 | Adaptive hypoxic tolerance in the subterranean mole rat Spalax ehrenbergi: the role of vascular endothelial growth factor |
| Q42476099 | Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells |
| Q45885596 | Adenovirus-mediated ex vivo gene transfer of human vascular endothelial growth factor in a rabbit laryngotracheal reconstruction model |
| Q73129425 | Angiogenesis and metastasis |
| Q35179424 | Angiogenesis inhibitors under study for the treatment of lung cancer |
| Q31923131 | Angiogenesis: regulators and clinical applications |
| Q34132821 | Angiogenesis: the role of the microenvironment in flipping the switch. |
| Q35207666 | Angiogenic factors in the central nervous system |
| Q35787877 | Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness |
| Q35104246 | Anti-angiogenic agents for the treatment of brain tumors |
| Q35067602 | Anti-inflammatory, antiangiogenic, and apoptosis-inducing activity of DLBS1442, a bioactive fraction of Phaleria macrocarpa, in a RL95-2 cell line as a molecular model of endometriosis. |
| Q37270713 | Autocrine VEGF Isoforms Differentially Regulate Endothelial Cell Behavior. |
| Q36399556 | Bartonella adhesin a mediates a proangiogenic host cell response |
| Q28201923 | Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability |
| Q34982237 | Brazilian green propolis inhibits inflammatory angiogenesis in a murine sponge model. |
| Q35751643 | CD13/APN is activated by angiogenic signals and is essential for capillary tube formation |
| Q34186417 | Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1α Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1α Protein |
| Q48010229 | Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer |
| Q40352151 | Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells. |
| Q28259513 | Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha |
| Q33712849 | Clinicopathological study on chronic encapsulated expanding hematoma associated with incompletely obliterated AVM after stereotactic radiosurgery |
| Q44183025 | Collateral arteries grow from preexisting anastomoses in the rat hindlimb |
| Q40299850 | Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways |
| Q79158465 | Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure |
| Q74296792 | Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier |
| Q28363915 | Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro |
| Q36283563 | Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway |
| Q24600049 | Current knowledge of the aetiology of human tubal ectopic pregnancy |
| Q46406301 | Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells |
| Q44062273 | Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts |
| Q36551258 | Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice |
| Q28510984 | Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death |
| Q59282175 | Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells |
| Q52200891 | Differential effects of kinase inhibitors on erythropoietin and vascular endothelial growth factor gene expression in rat hepatocytes. |
| Q71797339 | Divergent regulation of vascular endothelial growth factor and of erythropoietin gene expression in vivo |
| Q33868332 | Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma |
| Q36421457 | Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis |
| Q41126616 | Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation |
| Q35362327 | Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma |
| Q35745271 | Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice |
| Q35763510 | Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. |
| Q33723780 | Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C. |
| Q48567815 | Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia |
| Q46930509 | Effects of polycyclic aromatic hydrocarbons (PAHs) on vascular endothelial growth factor induction through phosphatidylinositol 3-kinase/AP-1-dependent, HIF-1alpha-independent pathway |
| Q44614679 | Effects of transcutaneous topical injection of oxygen on vascular endothelial growth factor gene into the healing ligament in rats |
| Q37565235 | Effects of tumor microenviromental factors on VEGF expression |
| Q37696032 | Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis |
| Q39312575 | Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model |
| Q33933781 | Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions |
| Q34375617 | Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer |
| Q40700482 | Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes |
| Q36438366 | Establishing a link between oncogenes and tumor angiogenesis |
| Q79661656 | Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast |
| Q55474992 | Expression and regulation of neuropilin-1 in human astrocytomas. |
| Q33791689 | Factors promoting tumor angiogenesis |
| Q37375400 | Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer |
| Q28137762 | Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2 |
| Q36562473 | Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor |
| Q36626925 | Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy. |
| Q43612836 | Gene therapy for malignant gliomas |
| Q41140305 | Gene therapy of malignant glioma via inhibition of tumor angiogenesis |
| Q35937600 | Genetics in zebrafish, mice, and humans to dissect congenital heart disease: insights in the role of VEGF. |
| Q41871117 | Growth factor mediated signaling in pancreatic pathogenesis |
| Q36193019 | Growth regulation of the vascular system: an emerging role for adenosine |
| Q28588778 | HIF-1 alpha is required for solid tumor formation and embryonic vascularization. |
| Q38346980 | HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels |
| Q42858934 | Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes |
| Q36653195 | Hyperbaric oxygen therapy for malignancy: a review. |
| Q51819032 | Hypoxia and low-nutrition double stress induces aggressiveness in a murine model of melanoma. |
| Q40153022 | Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells |
| Q36488739 | Hypoxia signalling in cancer and approaches to enforce tumour regression |
| Q58212136 | Hypoxia signalling in tumour angiogenesis |
| Q44176981 | Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo |
| Q35809808 | Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia |
| Q47795280 | Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology |
| Q77485489 | Hypoxia-inducible factor 1: master regulator of O2 homeostasis |
| Q40133024 | Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif |
| Q36301943 | Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. |
| Q38352366 | Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein |
| Q37236104 | Hypoxia-ischemia and retinal ganglion cell damage |
| Q36638165 | Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis |
| Q38610158 | Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements |
| Q54643252 | IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes. |
| Q53689233 | Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia. |
| Q36857442 | Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability |
| Q24537185 | Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. |
| Q40897164 | Identification of alternative spliced variants of human hypoxia-inducible factor-1alpha |
| Q55067238 | Immunohistochemical detection of vascular growth factors in angiomatous and atypical meningiomas, as well as hemangiopericytomas. |
| Q35651174 | Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis |
| Q51360163 | Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. |
| Q73059527 | Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro |
| Q35081587 | Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha |
| Q90270048 | Inflammatory Mechanisms of HCC Development |
| Q33568201 | Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid |
| Q22254113 | Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins |
| Q38282792 | Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma |
| Q40692956 | Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine |
| Q40729554 | Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway |
| Q83207678 | Ischemia-driven angiogenesis |
| Q39455739 | Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. |
| Q52970707 | Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. |
| Q47702562 | Levels of vascular endothelial growth factor and hepatocyte growth factor in sera of patients with rheumatic diseases. |
| Q33998089 | Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth |
| Q45736369 | Maternal serum placental growth factor at 11-13 weeks' gestation and fetal cardiac defects |
| Q24561970 | Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor |
| Q28236579 | Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells |
| Q37974518 | Metabolic reprogramming of the tumor. |
| Q45888006 | Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis |
| Q55477210 | Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor. |
| Q47849220 | Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis |
| Q34566028 | Molecular and functional diversity of vascular endothelial growth factors |
| Q35551132 | Molecular basis of angiogenesis and cancer |
| Q37828653 | Molecular mechanisms linking thrombosis and angiogenesis in cancer |
| Q34445877 | Molecular mechanisms of vasculogenesis and embryonic angiogenesis |
| Q38084684 | Monoclonal antibodies in gastrointestinal cancers. |
| Q32061166 | Mouse model of angiogenesis |
| Q39674949 | Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. |
| Q37286026 | Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein |
| Q39774393 | Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles |
| Q35052184 | Noninvasive MRI of endothelial cell response to human breast cancer cells. |
| Q37861206 | Notch regulation of tumor angiogenesis |
| Q26851211 | Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development |
| Q40364565 | Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1alpha eradicates gliomas |
| Q47684051 | Oxygen sensing and response to hypoxia by mammalian cells |
| Q41131070 | Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells |
| Q36220799 | Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate |
| Q33546314 | Placenta growth factor: potential role in pregnancy |
| Q41744346 | Positive and negative regulation of angiogenesis: from cell biology to the clinic |
| Q37285776 | Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene |
| Q42725868 | Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis |
| Q36472030 | Posttranscriptional mechanisms regulating the inflammatory response. |
| Q34633192 | Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. |
| Q34168165 | Probing high affinity sequences of DNA aptamer against VEGF165 |
| Q34805681 | Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice |
| Q33749480 | Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases |
| Q44838097 | Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. |
| Q64097634 | Qingre Baidu mixture-induced effect of AI-2 on and biofilms in chronic and refractory wounds |
| Q35547725 | Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging |
| Q22253321 | RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay |
| Q37360588 | Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo |
| Q41372654 | Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis |
| Q41140259 | Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis |
| Q40832375 | Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. |
| Q39946802 | Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance |
| Q58323583 | Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma |
| Q38296576 | Regulation of vascular endothelial growth factor expression by advanced glycation end products |
| Q36620509 | Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1beta |
| Q36622970 | Relationship of hypoxia to metastatic ability in rodent tumours |
| Q35759042 | Relative quantitative expression of hypoxia-inducible factor-1α, -2α and -3α, and vascular endothelial growth factor A in laryngeal carcinoma |
| Q38847743 | Repositioning the Old Fungicide Ciclopirox for New Medical Uses. |
| Q43777828 | Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression |
| Q35181953 | Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease |
| Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
| Q37669224 | Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane |
| Q48049530 | Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites |
| Q26800774 | Single Nucleotide Polymorphism in Patients with Moyamoya Disease |
| Q42502856 | Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells |
| Q52167716 | Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. |
| Q33615441 | Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors |
| Q43968903 | TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. |
| Q37229283 | Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis |
| Q35581391 | Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer |
| Q74473367 | The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor |
| Q49151264 | The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. |
| Q52141308 | The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. |
| Q35691471 | The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells |
| Q35748999 | The paracrinology of tubal ectopic pregnancy |
| Q34450594 | The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization |
| Q37521316 | The role of antiangiogenesis therapy: bevacizumab and beyond |
| Q38222585 | The role of targeted therapy for gastrointestinal tumors. |
| Q40622814 | The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture |
| Q24297372 | The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway |
| Q46627939 | The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy |
| Q33737967 | The vascular endothelial growth factor family: signalling for vascular development. |
| Q41376765 | The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis |
| Q36644262 | Thiram inhibits angiogenesis and slows the development of experimental tumours in mice |
| Q42527909 | Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines |
| Q28244565 | Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension |
| Q33686864 | Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response |
| Q35781926 | Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity. |
| Q41916797 | Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. |
| Q53393280 | Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. |
| Q41489951 | Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity |
| Q33772948 | Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia |
| Q36294602 | Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization |
| Q33775917 | Treatment of dural arteriovenous malformations and fistulas. |
| Q35202899 | Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. |
| Q48394604 | Upregulation of vascular endothelial growth factor in severe chronic brain hypoxia of the rat. |
| Q35745892 | VEGF expression by epithelial and stromal cell compartments: resolving a controversy |
| Q28375509 | VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism |
| Q34178821 | VEGF in brain tumors |
| Q37197773 | VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level |
| Q37352264 | VEGF-D promotes pulmonary oedema in hyperoxic acute lung injury |
| Q42450867 | Vascular Endothelial Growth Factor Expression and Angiogenesis Induced by Chronic Cerebral Hypoperfusion in Rat Brain |
| Q73129419 | Vascular endothelial growth factor |
| Q74080242 | Vascular endothelial growth factor |
| Q35674299 | Vascular endothelial growth factor activation of intramembranous absorption: a critical pathway for amniotic fluid volume regulation |
| Q40320902 | Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival. |
| Q33431623 | Vascular endothelial growth factor expression in heart of rats exposed to hypobaric hypoxia: differential response between mRNA and protein |
| Q48226237 | Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q56450866 | Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat |
| Q43850088 | Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells |
| Q40688027 | Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability |
| Q35764395 | Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. |
| Q24313128 | Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion |
| Q86029497 | Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q53930051 | [Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease] |
| Q33601639 | eIF4E expression in tumors: its possible role in progression of malignancies |
| Q34741148 | mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha |
Search more.